One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1136/annrheumdis-2020-eular.3711
Copy DOI Journal: Annals of the Rheumatic Diseases |  Publication Date: Jun 1, 2020 |
 Citations: 3 |
Affiliation: Boehringer Ingelheim (Switzerland), University of Michigan–Ann Arbor, Stanford University, Western University, Tulane University, University Hospital Schleswig-Holstein, University of Lübeck, Charité - Universitätsmedizin Berlin, Boehringer Ingelheim (Germany), University Hospital Carl Gustav Carus, TU DresdenBackground:In the SENSCIS trial in patients with SSc-ILD, nintedanib reduced the rate of decline in forced vital capacity (FVC) over 52 weeks. Elevated CRP is a marker of an inflammatory...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
